Related Experiment Videos
Neuroblastoma: evaluation with contrast enhanced MR imaging.
L Kornreich1, G Horev, C Kaplinsky
1Department of Pediatric Radiology, Beilinson Medical Center, Petah Tiqva, Israel.
Pediatric Radiology
|January 1, 1991
Summary
Gadolinium-diethylenetriaminepentaacetic acid (GD-DTPA) enhanced MRI is a new tool for evaluating pediatric neuroblastoma. This study details its diagnostic and follow-up capabilities for this childhood cancer.
Area of Science:
- Radiology
- Pediatric Oncology
- Medical Imaging
Background:
- Gadolinium-based contrast agents, such as GD-DTPA, are increasingly utilized in magnetic resonance imaging (MRI) for body applications.
- Neuroblastoma is a significant pediatric malignancy requiring accurate diagnostic and follow-up imaging modalities.
Purpose of the Study:
- To evaluate the effectiveness of GD-DTPA enhanced MRI in the diagnosis and follow-up of neuroblastoma in children.
- To describe the specific characteristics of tumor enhancement patterns observed with GD-DTPA enhanced MRI in pediatric neuroblastoma.
Main Methods:
- Retrospective review of pediatric patients with neuroblastoma who underwent MRI with GD-DTPA contrast enhancement.
- Analysis of imaging characteristics, including tumor enhancement patterns, size, and location.
- Correlation of imaging findings with clinical diagnosis and treatment response.
Main Results:
- GD-DTPA enhanced MRI provides detailed visualization of neuroblastoma, aiding in precise diagnosis.
- Specific enhancement patterns were identified, offering insights into tumor characteristics.
- The technique proved valuable in monitoring treatment response and detecting disease recurrence.
Conclusions:
- GD-DTPA enhanced MRI is a valuable tool for the comprehensive evaluation of pediatric neuroblastoma.
- Its ability to characterize tumor enhancement contributes significantly to diagnosis and patient management.
- This imaging modality supports effective follow-up strategies for children with neuroblastoma.